![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vac... Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California. Show more
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.175 | -7.20164609053 | 2.43 | 2.46 | 2.02 | 189817 | 2.21028599 | CS |
4 | -0.445 | -16.4814814815 | 2.7 | 2.85 | 2.02 | 196639 | 2.50033652 | CS |
12 | -2.995 | -57.0476190476 | 5.25 | 5.75 | 2.02 | 235987 | 3.22918158 | CS |
26 | -11.885 | -84.0523338048 | 14.14 | 16.6 | 2.02 | 173502 | 5.341093 | CS |
52 | -31.905 | -93.3987119438 | 34.16 | 35.15 | 2.02 | 168097 | 12.83974482 | CS |
156 | -3.745 | -62.4166666667 | 6 | 40.98 | 2.02 | 146846 | 14.47756956 | CS |
260 | -3.745 | -62.4166666667 | 6 | 40.98 | 2.02 | 146846 | 14.47756956 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions